pillbase.ru

BRILINTA

Active substance: ticagrelor

TABLET · TICAGRELOR 60 mg/1

United StatesActive

Marketing holder: AstraZeneca Pharmaceuticals LP

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Brilique
    ticagrelor
    EMEA/H/C/001241
    AstraZeneca AB
  • Possia
    ticagrelor
    EMEA/H/C/002303
    AstraZeneca AB
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-3293-7642-bacc-1bdb82e5f8d4,01a1208c-4845-704f-b030-e0d60437b88e,01a1208c-51a7-7827-984b-07c68f16828c,01a1208c-83e2-78ea-97ff-4f62c1ff24ee,01a1208c-b2d9-7ed0-be81-40724f376bb0;count=56 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0186-0776
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 0186-0776 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0186-0776 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0186-0776 · Verified 2026-10-09 · open in source